The pathogenesis of feline vaccine site-associated sarcomas (VSSs) remains obscure. The low prevalence of VSSs suggests that congenital or acquired genetic factors within individual susceptible cats may act as initiators of oncogenesis. The purpose of this study was to investigate potential viral candidates in the etiopathogenesis of VSSs. Retroviruses investigated included feline immunodeficiency virus (FIV), feline foamy virus (FeFV) and endogenous feline leukemia virus (enFeLV). Vaccination could increase replication and/or expression of latent retroviruses or endogenous retroviruses within proliferating fibroblasts and/or inflammatory cells. Malignant transformation could then result from insertional activation or inactivat...
AbstractFeline leukemia virus (FeLV) subgroup B arises de novo through recombination between the env...
A naturally occurring feline thymic lymphosarcoma (T17) provided the unique observation of a T-cell ...
The feline leukemia virus (FeLV) causes degenerative and proliferative hemolymphatic diseases in dom...
The pathogenesis of feline vaccine site-associated sarcomas (VSSs) remains obscure. The low prevale...
Corey F Saba Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, Univer...
~ p m e n t. ~ J I J ~ Although FSV infection in FeLV positive cats can result in fibroblast transf...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
Feline leukaemia virus has been a particularly useful tool in cancer research since many of the natu...
Feline injection-site sarcomas (FISS) are known since the beginning of 90s. After the first correlat...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
BACKGROUND: Cats infected with exogenous feline leukemia virus (exFeLV) have a higher chance of lymp...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Feline injection site sarcoma (FISS), formerly known as Vaccine Associated Sarcoma (VAS) is a rare, ...
Background Cats infected with exogenous feline leukemia virus (exFeLV) have a higher chance of lymp...
In cats, the most serious of adverse effects following vaccination is the occurrence of invasive sar...
AbstractFeline leukemia virus (FeLV) subgroup B arises de novo through recombination between the env...
A naturally occurring feline thymic lymphosarcoma (T17) provided the unique observation of a T-cell ...
The feline leukemia virus (FeLV) causes degenerative and proliferative hemolymphatic diseases in dom...
The pathogenesis of feline vaccine site-associated sarcomas (VSSs) remains obscure. The low prevale...
Corey F Saba Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, Univer...
~ p m e n t. ~ J I J ~ Although FSV infection in FeLV positive cats can result in fibroblast transf...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
Feline leukaemia virus has been a particularly useful tool in cancer research since many of the natu...
Feline injection-site sarcomas (FISS) are known since the beginning of 90s. After the first correlat...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
BACKGROUND: Cats infected with exogenous feline leukemia virus (exFeLV) have a higher chance of lymp...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Feline injection site sarcoma (FISS), formerly known as Vaccine Associated Sarcoma (VAS) is a rare, ...
Background Cats infected with exogenous feline leukemia virus (exFeLV) have a higher chance of lymp...
In cats, the most serious of adverse effects following vaccination is the occurrence of invasive sar...
AbstractFeline leukemia virus (FeLV) subgroup B arises de novo through recombination between the env...
A naturally occurring feline thymic lymphosarcoma (T17) provided the unique observation of a T-cell ...
The feline leukemia virus (FeLV) causes degenerative and proliferative hemolymphatic diseases in dom...